Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of LAMEA Oncology/Anti-cancer drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of LAMEA Oncology/Anti-cancer drugsmarket, defines the market attractiveness level of LAMEA Oncology/Anti-cancer drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of LAMEA Oncology/Anti-cancer drugs industry, describes the types of LAMEA Oncology/Anti-cancer drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global LAMEA Oncology/Anti-cancer drugs market and the development prospects and opportunities of LAMEA Oncology/Anti-cancer drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global LAMEA Oncology/Anti-cancer drugs market in Chapter 13.
By Player:
Pfizer
Merck & Co
Johnson & Johnson
Eli lilly & Co
Roche
Amgen
Sanofi
GlaxoSmithKline
Novartis
Celgene
By Type:
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Others
By End-User:
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 LAMEA Oncology/Anti-cancer drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 LAMEA Oncology/Anti-cancer drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 LAMEA Oncology/Anti-cancer drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 LAMEA Oncology/Anti-cancer drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise LAMEA Oncology/Anti-cancer drugs Market Analysis and Outlook to 2022
-
7.1 Global LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
-
7.2 United States LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
-
7.3 Europe LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
-
7.4 China LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
-
7.5 Japan LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
-
7.6 India LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
-
7.7 South Korea LAMEA Oncology/Anti-cancer drugs Consumption (2017-2022)
8 Region and Country-wise LAMEA Oncology/Anti-cancer drugs Market Analysis and Outlook to 2028
-
8.1 Global LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
-
8.2 United States LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
-
8.3 Europe LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
-
8.4 China LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
-
8.5 Japan LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
-
8.6 India LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
-
8.7 South Korea LAMEA Oncology/Anti-cancer drugs Consumption Forecast (2022-2028)
9 Global LAMEA Oncology/Anti-cancer drugs Market Outlook by Types and Applications to 2022
-
9.1 Global LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Immunotherapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global LAMEA Oncology/Anti-cancer drugs Market Outlook by Types and Applications to 2028
-
10.1 Global LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Immunotherapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global LAMEA Oncology/Anti-cancer drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global LAMEA Oncology/Anti-cancer drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global LAMEA Oncology/Anti-cancer drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 LAMEA Oncology/Anti-cancer drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global LAMEA Oncology/Anti-cancer drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.2 Merck & Co
-
14.2.1 Merck & Co Company Details
-
14.2.2 Merck & Co LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.4 Eli lilly & Co
-
14.4.1 Eli lilly & Co Company Details
-
14.4.2 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.8 GlaxoSmithKline
-
14.8.1 GlaxoSmithKline Company Details
-
14.8.2 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis LAMEA Oncology/Anti-cancer drugs Product and Service
-
14.10 Celgene
-
14.10.1 Celgene Company Details
-
14.10.2 Celgene LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Celgene LAMEA Oncology/Anti-cancer drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of LAMEA Oncology/Anti-cancer drugs
-
Figure LAMEA Oncology/Anti-cancer drugs Picture
-
Table Global LAMEA Oncology/Anti-cancer drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global LAMEA Oncology/Anti-cancer drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global LAMEA Oncology/Anti-cancer drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global LAMEA Oncology/Anti-cancer drugs Consumption by Country (2017-2022)
-
Figure United States LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate (2017-2022)
-
Table Europe LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate (2017-2022)
-
Figure China LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate (2017-2022)
-
Figure India LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea LAMEA Oncology/Anti-cancer drugs Consumption and Growth Rate (2017-2022)
-
Figure Global LAMEA Oncology/Anti-cancer drugs Consumption Forecast by Country (2022-2028)
-
Figure United States LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea LAMEA Oncology/Anti-cancer drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy (Biologic Therapy) Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy (Biologic Therapy) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global LAMEA Oncology/Anti-cancer drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global LAMEA Oncology/Anti-cancer drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Eli lilly & Co (Foundation Year, Company Profile and etc.)
-
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis LAMEA Oncology/Anti-cancer drugs Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene LAMEA Oncology/Anti-cancer drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene LAMEA Oncology/Anti-cancer drugs Product and Service
-
